Cargando…
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
The coronavirus disease 2019 (COVID-19) is an unprecedented pandemic that has severely impacted global public health and the economy. Hydroxychloroquine administered orally to COVID-19 patients was ineffective, but its antiviral and anti-inflammatory actions were observed in vitro. The lack of effic...
Autores principales: | Tai, Waiting, Chow, Michael Yee Tak, Chang, Rachel Yoon Kyung, Tang, Patricia, Gonda, Igor, MacArthur, Robert B., Chan, Hak-Kim, Kwok, Philip Chi Lip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399722/ https://www.ncbi.nlm.nih.gov/pubmed/34452220 http://dx.doi.org/10.3390/pharmaceutics13081260 |
Ejemplares similares
-
Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
por: McGrath, James A., et al.
Publicado: (2019) -
Phase 1 Randomized Placebo-Controlled Study in Healthy Adult Volunteers to Evaluate the Safety, Tolerability, and Pharmacokinetics of Orally Inhaled Aerosolized Hydroxychloroquine Sulfate – A Potential Treatment for COVID-19
por: Bentur, Ohad, et al.
Publicado: (2021) -
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
por: Yau, Grace Tsz Yan, et al.
Publicado: (2023) -
Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals
por: Cipolla, David, et al.
Publicado: (2015) -
Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)